APA (7th ed.) Citation

Vanderlinden, L., Polinski, K., Demoruelle, K., Feser, M., Seifert, J., Mikuls, T., . . . Norris, J. (2023). OP0125 LIPID MEDIATOR PROFILES ASSOCIATE WITH PROGRESSION TO RA IN ANTI-CITRULLINATED PROTEIN ANTIBODY POSITIVE POPULATIONS. Annals of the rheumatic diseases, 82(Suppl 1), 81-82. https://doi.org/10.1136/annrheumdis-2023-eular.4775

Chicago Style (17th ed.) Citation

Vanderlinden, L., et al. "OP0125 LIPID MEDIATOR PROFILES ASSOCIATE WITH PROGRESSION TO RA IN ANTI-CITRULLINATED PROTEIN ANTIBODY POSITIVE POPULATIONS." Annals of the Rheumatic Diseases 82, no. Suppl 1 (2023): 81-82. https://doi.org/10.1136/annrheumdis-2023-eular.4775.

MLA (9th ed.) Citation

Vanderlinden, L., et al. "OP0125 LIPID MEDIATOR PROFILES ASSOCIATE WITH PROGRESSION TO RA IN ANTI-CITRULLINATED PROTEIN ANTIBODY POSITIVE POPULATIONS." Annals of the Rheumatic Diseases, vol. 82, no. Suppl 1, 2023, pp. 81-82, https://doi.org/10.1136/annrheumdis-2023-eular.4775.